Protein C Deficiency caused by Homozygosity for a Novel PROC D180G Mutation – in vitro Expression and Structural Analysis of the Mutation

 

 Buy Article Permissions and Reprints

Summry

Homozygosity for a novel D180G mutation in the protease domain of protein C, associated with plasma protein C activity and antigen levels of 8% of normal was identified in a thrombosis prone family. Transient expression of protein C in HK-293 cells and analysis of protein C antigen in culture media and cell lysates showed that the secretion of mutant protein as compared with wild-type protein was reduced by 79% while the intracellular contents were similar. Computer analysis of the X-ray structure of activated protein C and of a theoretical model of the zymogen predicts that the mutation destabilises the molecule locally. Our results are compatible with a relatively unstable mutant molecule that could be trapped inside the cell and degraded. However, if secreted the mutant molecule could have a relatively normal catalytic activity and structure consistent with the plasma levels of protein C activity and the late onset of thrombosis.

• References

• 1 Dahlbäck B. The protein C anticoagulant system: Inherited defects as basis for venous thrombosis. Thromb Res 1995; 77: 1-43.
  CrossrefPubMedGoogle Scholar
• 2 Cooper DN, Krawczak M. Protein C and protein C deficiency. In: Venous thrombosis from genes to clinical medicine. The molecular genetics of an archetypal multigene disorder. Cooper DN, Krawczak M. eds. Oxford: BIOS Scientific Publishers Ltd; 1997: 61-96.
  Google Scholar
• 3 Sallah S, Thomas DP, Roberts HR. Warfarin and heparin-induced skin necrosis and the purple toe syndrome: Infrequent complications of anticoagulant treatment. Thromb Haemost 1997; 78: 785-90.
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Reitsma PH, Bernardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN. Protein C deficiency: A database of mutations, 1995 update. Thromb Haemost 1995; 73: 876-89.
  Article in Thieme ConnectPubMedGoogle Scholar
• 5 Aiach M, Gandrille S, Emmerich J. A review of mutations causing deficiencies of antithrombin, protein C and protein S. Thromb Haemost 1995; 74: 81-9.
  Article in Thieme ConnectPubMedGoogle Scholar
• 6 Simioni P, Kalafatis M, Millar DS, Henderson SC, Luni S, Cooper DN, Girolami A. Compound heterozygous protein C deficiency resulting in the presence of only the b-form of protein C in plasma. Blood 1996; 88: 2101-8.
  PubMedGoogle Scholar
• 7 Millar DS, Johansen B, Berntorp E, Minford A, Bolton-Maggs P, Wensley R, Kakkar V, Schulman S, Torres A, Bosch N, Cooper DN. Molecular genetic analysis of severe protein C deficiency. Hum Genet 2000; 106: 646-53.
  PubMedGoogle Scholar
• 8 Nakayama T, Matsushita T, Hidano H, Suzuki C, Hamaguchi M, Kojima T, Saito H. A case of purpura fulminans is caused by homozygous delta8857 mutation (protein C-Nagoya) and successfully treated with activated protein C concentrate. Br J Haematol 2000; 110: 727-30.
  CrossrefPubMedGoogle Scholar
• 9 Soria JM, Morell M, Nicolau I, Estivill X, Sala N. Homozygosity for R87H missense mutation and for a rare intron 7 DNA variant (7054G ? A) in the PROC genes of three siblings initially classified as heterozygotes for protein C deficiency. Blood Coagul Fibrinolysis 1996; 07: 15-23.
  CrossrefPubMedGoogle Scholar
• 10 Monagle P, Andrew M, Halton J, Marlar R, Jardine L, Vegh P, Johnston M, Webber C, Massicotte MP. Homozygous protein C deficiency: Description of a new mutation and successful treatment with low molecular weight heparin. Thromb Haemost 1998; 79: 756-61.
  Article in Thieme ConnectPubMedGoogle Scholar
• 11 Sanz-Rodriguez C, Gil-Fernández JJ, Zapater P, Pinilla I, Granados E, De Soria G-GV, Cano J, Sala N, Fernández-Ranada JM, Gómez-Gómez N. Long-term management of homozygous protein C deficiency: replacement therapy with subcutaneous purified protein C concentrate. Thromb Haemost 1999; 81: 887-90.
  Article in Thieme ConnectPubMedGoogle Scholar
• 12 Kemahli S, Alhenc-Gelas M, Gandrille S, Aiach M, Akar N, Cin S. Homozygous protein C deficiency with a double variant his 202 to Tyr and Ala 346 to Thr. Blood Coagul Fibrinolysis 1998; 09: 351-4.
  CrossrefPubMedGoogle Scholar
• 13 Alhenc-Gelas M, Gandrille S, Aubry ML, Aiach M. Thirty-three novel mutations in the protein C gene. Thromb Haemost 2000; 83: 86-92.
  Article in Thieme ConnectPubMedGoogle Scholar
• 14 Miyata T, Sakata T, Yasumuro Y, Okamura T, Katsumi A, Saito H, Abe T, Shirahata A, Sakai M, Kato H. Genetic analysis of protein C deficiency in nineteen Japanese families: Five recurrent defects can explain half of the deficiencies. Thromb Res 1998; 92: 181-87.
  CrossrefPubMedGoogle Scholar
• 15 Poort SR, Pabinger-Fasching I, Mannhalter C, Reitsma PH, Bertina RM. Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiency. Blood Coagul Fibrinolysis 1993; 04: 273-80.
  CrossrefPubMedGoogle Scholar
• 16 Hallam PJ, Mannucci PM, Tripodi A, Bevan D, Laursen B, Tengborn L, Wacey A, Cooper DN. Three novel PROC gene lesions causing protein C deficiency. Clin Genet 1998; 54: 231-3.
  PubMedGoogle Scholar
• 17 Cooper DN, Ball EV, Krawczak M. The human gene mutation database. Nucleic Acids Res 1998; 26: 285-7.
  CrossrefPubMedGoogle Scholar
• 18 Lind B, Johnsen AH, Thorsen S. Naturally occurring Arg-1 to His mutation in human protein C leads to aberrant propeptide processing and secretion of dysfunctional protein C. Blood 1997; 89: 2807-16.
  PubMedGoogle Scholar
• 19 Lind B, Koefoed P, Thorsen S. Symptomatic type 1 protein C deficiency caused by a de novo Ser270Leu mutation in the catalytic domain. Br J Haematol 2001; 113: 642-8.
  CrossrefPubMedGoogle Scholar
• 20 Beckmann RJ, Schmidt RJ, Santerre RF, Plutzky J, Crabtree GR, Long GL. The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs. Nucleic Acids Res 1985; 13: 5233-47.
  CrossrefPubMedGoogle Scholar
• 21 Mather T, Oganessyan V, Hof P, Huber R, Foundling S, Esmon C, Bode W. The 2.8 Å crystal structure of Gla-domainless activated protein C. EMBO J 1996; 15: 6822-31.
  PubMedGoogle Scholar
• 22 Vijayalakshmi J, Padmanabhan KP, Mann KG, Tulinsky A. The isomorphous structures of prethrombin 2, hirugen-, and PPACK-thrombin: Changes accompanying activation and exosite binding to thrombin. Protein Sci 1994; 03: 2254-71.
  CrossrefPubMedGoogle Scholar
• 23 Villoutreix BO, Covell DG, Blom AM, Wallquist A, Friedrich U, Dahlbäck B. Screening the molecular surface of human anticoagulant protein C: A search for interaction sites. J Comput-Aided Mol Des 2001; 15: 13-27.
  PubMedGoogle Scholar
• 24 Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 1985; 82: 4673-7.
  CrossrefPubMedGoogle Scholar
• 25 Reitsma PH, Poort SR, Allaart CF, Briët E, Bertina RM. The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: Heterogeneity and founder effects. Blood 1991; 78: 890-4.
  PubMedGoogle Scholar
• 26 Overington J, Donnelly D, Johnson MS, Sali A, Blundell TL. Environmentspecific amino acid substitution tables: Tertiary templates and prediction of protein folds. Protein Sci 1992; 1992: 216-26.
  PubMedGoogle Scholar
• 27 Wang Z, Moult J. SNPs, protein structure, and disease. Hum Mutat 2001; 17: 263-70.
  CrossrefPubMedGoogle Scholar
• 28 Bross P, Corydon TJ, Andresen BS, Jørgensen MM, Bolund L, Gregersen N. Protein misfolding and degradation in genetic diseases. Hum Mutat 1999; 14: 186-98.
  CrossrefPubMedGoogle Scholar
• 29 Wickner S, Maurizi MR, Gottesman S. Posttranslational quality control: Folding, refolding and degrading proteins. Science 1999; 286: 1888-93.
  CrossrefPubMedGoogle Scholar